Insider Trading July 8, 2026 06:07 PM

Stitch Fix CPTO Bacos Executes $265K Share Sale Under Pre-Arranged Plan

Anthony Bacos liquidates 70,000 shares while exercising stock options, as the company navigates recent leadership changes and AI platform expansion amid mixed analyst sentiment.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
SFIX

Anthony Bacos, Stitch Fix's Chief Product and Technology Officer, executed a series of transactions on July 6, 2026, selling 70,000 shares of Class A Common Stock valued at $265,089. These sales were conducted under a Rule 10b5-1 trading plan established in March 2026. The transactions occurred against a backdrop of recent financial results that beat Wall Street expectations and ongoing strategic initiatives, including the expansion of its AI style visualization platform, Stitch Fix Vision.

Stitch Fix CPTO Bacos Executes $265K Share Sale Under Pre-Arranged Plan
SFIX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Anthony Bacos sold 70,000 shares for $265,089 under a Rule 10b5-1 plan, while also exercising options for 50,000 shares at $2.48 per share.
  • Stitch Fix reported fiscal Q3 2026 results that beat Wall Street expectations, with revenue of $340.3 million and an adjusted loss of $0.01 per share.
  • The company is expanding its AI capabilities with the new "See it on me" feature and has appointed Sree Sreedhararaj as the new Chief Product and Technology Officer.

Anthony Bacos, who serves as the Chief Product and Technology Officer at Stitch Fix, Inc. (NASDAQ: SFIX), executed a significant series of transactions on July 6, 2026, resulting in the sale of 70,000 shares of the company's Class A Common Stock. The total value realized from these sales was $265,089. These transactions were carried out in accordance with a Rule 10b5-1 trading plan that was established on March 17, 2026.

The liquidation of shares was not a single event but rather comprised two distinct transactions. In the first phase, Mr. Bacos sold 50,000 shares at a weighted average price of $3.7965 per share. These specific shares were sold across multiple transactions, with individual prices ranging from $3.705 to $3.845 per share. A subsequent sale involved the disposal of 20,000 shares at a weighted average price of $3.7632 per share. The individual transaction prices for this second batch ranged from $3.71 to $3.84 per share. The overall price range for the total sales activity fell between $3.7632 and $3.7965 per share.

These insider transactions take place while Stitch Fix shares have experienced a sharp decline. The stock has dropped 11% over the past week and 30% over the last six months, currently trading at $3.56. According to InvestingPro analysis, the stock appears undervalued at current levels, with a Fair Value estimate suggesting potential upside. The company holds more cash than debt on its balance sheet, one of 12 key InvestingPro Tips available to subscribers. For deeper insights, investors can access the comprehensive Pro Research Report, available for SFIX and 1,400+ other US equities.

Preceding these sales on the same day, Mr. Bacos acquired 50,000 shares of Class A Common Stock by exercising employee stock options at a price of $2.48 per share, totaling $124,000. These options were also exercised under the Rule 10b5-1 plan. The options had an expiration date of April 1, 2034, with a vesting schedule that began on June 12, 2024, and continued in various quarterly installments.

Following these transactions, Mr. Bacos directly owns 1,031,994 shares of Stitch Fix Class A Common Stock. He also holds 522,543 derivative shares in the form of employee stock options.

In other recent news, Stitch Fix reported fiscal third-quarter 2026 results that surpassed Wall Street’s expectations in both earnings and revenue. The company posted an adjusted loss of $0.01 per share, which was narrower than analysts’ predictions, and generated revenue of $340.3 million, exceeding the anticipated $332.56 million. Following these results, Stitch Fix also raised its full-year revenue and EBITDA guidance. Despite these positive developments, Mizuho reiterated an Underperform rating for Stitch Fix, citing rising costs as a concern, and maintained a $3.00 price target.

Additionally, Stitch Fix has expanded its AI style visualization platform, Stitch Fix Vision, with a new feature called "See it on me." This feature allows clients to generate personalized images of themselves wearing recommended outfits. In leadership news, the company appointed Sree Sreedhararaj as Chief Product and Technology Officer, who will oversee technology, product, data science, security, and IT teams. These developments highlight Stitch Fix’s ongoing efforts to enhance its platform and leadership team.

Risks

  • Mizuho has reiterated an Underperform rating for Stitch Fix, citing rising costs as a primary concern, maintaining a $3.00 price target.
  • Stitch Fix shares have declined sharply, dropping 11% over the past week and 30% over the last six months, currently trading at $3.56.

More from Insider Trading

Meta Platforms COO Javier Olivan Executes $3.15 Million Share Sale Under Pre-Arranged Trading Plan Jul 8, 2026 Palisade Bio Director Robert Baltera Jr. Expands Stake with $102K Share Purchase Jul 8, 2026 Palisade Bio Executive Offloads Shares to Meet Tax Obligations Amid Clinical Milestones Jul 8, 2026 Palisade Bio Leadership Executes Strategic Stock Transactions Amid Clinical Milestones Jul 8, 2026 AppLovin Director Maynard Webb Executes $1.6M Stock Sale Under Pre-Arranged Plan Jul 8, 2026